Ohio Chapter Members,
On behalf of the Education Committee, I invite you to join us on Thursday August 15th at 1pm for an exciting debate on the role of Andexanet alfa for Xa inhibitor-associated intracerebral hemorrhage. An expert panel of ICU physicians and pharmacists from across the state will be sharing the pros and cons of the most recent ANNEXA trial.
Free registration is required: https://bit.ly/46mRWjG
------------------------------
Bethany Mocas, PharmD, BCCCP
Cleveland Clinic
------------------------------